THUR, SEP 12, 2013 | Satellite Symposium Targeting gut hormones: effects on appetite, weight and cardiometabolic outcomes |
Convention Hall C (4F) |
---|---|---|
15:00-17:00 | Learning objectives - Raise awareness of the clinical effects of treatments targeting gut hormone signalling - Assist physicians in implementing tailored treatment strategies for improved outcomes |
|
15:00–15:05 | Introduction and welcome | Luc Van Gaal Antwerp University Hospital, Belgium |
15:05–15:30 | Addressing multifactorial risks in obesity/cardiometabolic disease | Juliana Chan Hong Kong Institute of Diabetes and Obesity, Hong Kong |
15:30–15:55 | Pharmacotherapy for weight management: past, present and future | Luc Van Gaal Antwerp University Hospital, Belgium |
15:55–16:20 | Gut hormones in the anti-diabetic effects of bariatric surgery | André Carpentier Sherbrooke University, Canada |
16:20–16:50 | Interactive case study: presentation highlighting challenges of obesity management | All |
16:50-17:00 | Group discussion |
FRI, SEP 13, 2013 | Luncheon Symposium | Convention Hall C (4F) |
---|---|---|
12:45-13:45 | Chairperson: Moon-Kyu Lee | |
The Role of Statins in LDL Management and Beyond | Peter Libby Brigham and Women's Hospital Boston, USA |
|
Panels : Yong Soo Park, Ick Mo Chung, Kyung Mook Choi, Hweung Kon Hwang |
SAT, SEP 14, 2013 | Luncheon Symposium | Convention Hall C (4F) |
---|---|---|
12:30-13:30 | Chairperson: Dong-Soo Kim | |
Cardiovascular Risk Factors Management in Asymptomatic Hypertensive Subjects | Hyuk-Jae Chang Yonsei University, Korea |